Search Results

There are 7251365 results for: content related to: Surrogate endpoints in clinical trials: Definition and operational criteria

  1. Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 226–232, Debashis Ghosh, Jeremy M. G. Taylor and Daniel J. Sargent

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01633.x

  2. Statistical evaluation of biomarkers as surrogate endpoints: a literature review

    Statistics in Medicine

    Volume 25, Issue 2, 30 January 2006, Pages: 183–203, Christopher J. Weir and Rosalind J. Walley

    Version of Record online : 26 OCT 2005, DOI: 10.1002/sim.2319

  3. Does the Prentice criterion validate surrogate endpoints?

    Statistics in Medicine

    Volume 23, Issue 10, 30 May 2004, Pages: 1571–1578, Vance W. Berger

    Version of Record online : 27 APR 2004, DOI: 10.1002/sim.1780

  4. Estimating treatment difference for binary responses in the presence of surrogate endpoints

    Statistics in Medicine

    Volume 30, Issue 2, 30 January 2011, Pages: 186–196, Buddhananda Banerjee and Atanu Biswas

    Version of Record online : 20 OCT 2010, DOI: 10.1002/sim.4089

  5. A survey of endpoint characteristics in periodontal clinical trials published 1988–1992, and implications for future studies

    Journal of Clinical Periodontology

    Volume 22, Issue 5, May 1995, Pages: 397–407, P. P. Hujoel and T. A. DeRouen

    Version of Record online : 13 DEC 2005, DOI: 10.1111/j.1600-051X.1995.tb00167.x

  6. Discussions

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 239–241, Vance W. Berger, Grant Izmirlian and Diana Knoll

    Version of Record online : 22 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01636.x

  7. You have free access to this content
    On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints

    Biometrics

    Volume 71, Issue 1, March 2015, Pages: 15–24, Ariel Alonso, Wim Van der Elst, Geert Molenberghs, Marc Buyse and Tomasz Burzykowski

    Version of Record online : 1 OCT 2014, DOI: 10.1111/biom.12245

  8. Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation

    Pharmaceutical Statistics

    Volume 5, Issue 3, July/September 2006, Pages: 173–186, Tomasz Burzykowski and Marc Buyse

    Version of Record online : 10 MAY 2006, DOI: 10.1002/pst.207

  9. Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints

    Biometrics

    Volume 60, Issue 3, September 2004, Pages: 724–728, Ariel Alonso, Geert Molenberghs, Tomasz Burzykowski, Didier Renard, Helena Geys, Ziv Shkedy, Fabián Tibaldi, José Cortiñas Abrahantes and Marc Buyse

    Version of Record online : 27 AUG 2004, DOI: 10.1111/j.0006-341X.2004.00222.x

  10. Surrogate endpoints in clinical trials: Cardiovascular diseases

    Statistics in Medicine

    Volume 8, Issue 4, April 1989, Pages: 415–425, Janet Wittes, Edward Lakatos and Jeffrey Probstfield

    Version of Record online : 12 OCT 2006, DOI: 10.1002/sim.4780080405

  11. Discussion of the Paper of Ghosh, Taylor, and Sargent

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 236–238, Edward L. Korn

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01635.x

  12. Surrogate Measures and Consistent Surrogates

    Biometrics

    Volume 69, Issue 3, September 2013, Pages: 561–565, Tyler J. VanderWeele

    Version of Record online : 23 SEP 2013, DOI: 10.1111/biom.12071

  13. Statistical evaluation of surrogate endpoints with examples from cancer clinical trials

    Biometrical Journal

    Volume 58, Issue 1, January 2016, Pages: 104–132, Marc Buyse, Geert Molenberghs, Xavier Paoletti, Koji Oba, Ariel Alonso, Wim Van der Elst and Tomasz Burzykowski

    Version of Record online : 12 FEB 2015, DOI: 10.1002/bimj.201400049

  14. Rejoinder for “Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling”

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 245–247, Debashis Ghosh, Jeremy M. G. Taylor and Daniel J. Sargent

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01638.x

  15. Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes

    Statistics in Medicine

    Volume 20, Issue 20, 30 October 2001, Pages: 3023–3038, Geert Molenberghs, Helena Geys and Marc Buyse

    Version of Record online : 3 OCT 2001, DOI: 10.1002/sim.923

  16. Discussion Contribution to 091037PR4 (Ghosh, Taylor, and Sargent)

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 233–235, Geert Molenberghs

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01634.x

  17. On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm

    Biometrics

    Volume 65, Issue 2, June 2009, Pages: 521–529, Debashis Ghosh

    Version of Record online : 27 AUG 2008, DOI: 10.1111/j.1541-0420.2008.01109.x

  18. Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements

    Biometrical Journal

    Volume 45, Issue 8, December 2003, Pages: 931–945, Ariel Alonso, Helena Geys, Geert Molenberghs, Michael G. Kenward and Tony Vangeneugden

    Version of Record online : 9 DEC 2003, DOI: 10.1002/bimj.200390061

  19. Discussion by O'Quigley and Flandre

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 242–244, John O'Quigley and Philippe Flandre

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1541-0420.2011.01637.x

  20. Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time

    Biometrics

    Volume 68, Issue 1, March 2012, Pages: 248–257, Stuart G. Baker, Daniel J. Sargent, Marc Buyse and Tomasz Burzykowski

    Version of Record online : 13 AUG 2011, DOI: 10.1111/j.1541-0420.2011.01646.x